Prevalence of high-level aminoglycoside and vancomycin-resistant enterococcus species at a tertiary care hospital in greater noida, u.p
- 1. Sharda University
Description
Author:
Reshu Chauhan., Tarana Sarwat and Dalip K Kakru
Background: Enterococcal infection has emerged as a major therapeutic challenge. Exposure of High- Level Aminoglycoside Resistance (HLAR) and Vancomycin-Resistant among Enterococcus species has further limited the drug in Enterococcal infections.
Objective: To estimate the prevalence of High- Level Aminoglycoside Resistant (HLAR), i.e HLG and HLS resistance and Vancomycin-Resistant among Enterococcus species at a tertiary care hospital in Greater Noida.
Material & Methods: A total of 80 isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using Kirby- Bauer disc diffusion method and the Epsilometer test (E- test) and Vitek automated as per standard protocol.
Results: Eighty out of 13,639 culture-positive clinical samples comprising of 48 urine, 15 from pus, 6 blood, 5 vaginal swabs, 2 ETT, 1 BAL, and 1 tissue fluid(Pleural fluid) isolates were identified as Enterococcus faecalis (57.5%), Enterococcus faecium (35%), Enterococcus durans (5%), and Enterococcus gallinarum (2.5%). The majority of the isolates (61.25%) were from a urine specimen. While High-Level Aminoglycoside Resistance was seen in 71.62% of the isolates. Vancomycin-Resistant Enterococci were found to be majorly in urine isolates.
Conclusions: The petrifying rise in the prevalence of Vancomycin and multidrug resistance strains authorize immediate, sufficient, and efficient surveillance programs to prevent and control its spread.
Files
Research article Reshu 2021.pdf
Files
(362.9 kB)
Name | Size | Download all |
---|---|---|
md5:e397257388e5ba731fba444099192564
|
362.9 kB | Preview Download |